CompletedNCT02982915
Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
PHASE1 · PHASE2 · 62 planned enrolment
- Countries listed
- 1
- Registry update
- November 4, 2022
immortal.lifeTrial registrations containing the exact intervention label Longeveron Mesenchymal Stem Cells (LMSCs).
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE1 · PHASE2 · 62 planned enrolment
PHASE2 · 150 planned enrolment